Related Experiment Video
Updated: Sep 29, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Downregulation of miR-211-5p Promotes Carboplatin Resistance in Human Retinoblastoma Y79 Cells by Affecting the
Ning Ke1, Lin Chen1, Qing Liu1
1Department of Ophthalmology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Purpose:
To investigate the role of the miR-211-5p-GDNF signaling pathway in carboplatin resistance of retinoblastoma Y79 cells and what factors it may be affected by.
Methods:
A carboplatin-resistant retinoblastoma cell line (Y79R) was established in vitro. RNA-seq and microRNA-seq were constructed between Y79 and Y79R cells. RNA interference, RT-PCR, Western blot (WB), and flow cytometry were used to verify the expression of genes and proteins between the two cell lines. The TargetScan database was used to predict the microRNAs that regulate the target genes. STING sites and Co-Immunoprecipitation (COIP) were used to study protein-protein interactions.
Results:
GDNF was speculated to be the top changed gene in the drug resistance in Y79R cell lines. Moreover, the speculation was verified by subsequent RT-PCR and WB results. When the expression of GDNF was knocked down, the IC50 of the Y79R cell line significantly reduced. GDNF was found to be the target gene of miR-211-5p. Downregulation of miR-211-5p promotes carboplatin resistance in human retinoblastoma Y79 cells. MiR-211-5p can regulate the expression of GDNF. Our further research also found that GDNF can bind to LIF which is also a secreted protein.
Conclusion:
Our results suggest that downregulation of miR-211-5p promotes carboplatin resistance in human retinoblastoma Y79 cells, and this process can be affected by GDNF-LIF interaction. These results can provide evidence for the reversal of drug resistance of RB.
Insights
Downregulation of miR-211-5p promotes carboplatin resistance in retinoblastoma cells by affecting the GDNF-LIF interaction. This finding offers potential strategies for reversing drug resistance in retinoblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Retinoblastoma is a pediatric eye cancer.
- Carboplatin is a common chemotherapy agent used for retinoblastoma.
- Acquired drug resistance limits treatment efficacy.
Purpose of the Study:
- Investigate the role of the miR-211-5p-GDNF signaling pathway in carboplatin resistance.
- Identify factors influencing this pathway in retinoblastoma Y79 cells.
Main Methods:
- Established a carboplatin-resistant retinoblastoma cell line (Y79R).
- Utilized RNA-seq, microRNA-seq, RT-PCR, Western blot, and flow cytometry.
- Employed TargetScan, STING, and Co-Immunoprecipitation (COIP) for analysis.
Main Results:
- GDNF (Glial cell line-derived neurotrophic factor) was identified as a key gene in drug resistance.
- Downregulation of miR-211-5p increased carboplatin resistance in Y79 cells.
- GDNF was confirmed as a target of miR-211-5p and interacts with LIF (Leukemia Inhibitory Factor).
Conclusions:
- Downregulation of miR-211-5p promotes carboplatin resistance in retinoblastoma Y79 cells.
- The GDNF-LIF interaction influences this drug resistance mechanism.
- Findings may guide strategies for reversing carboplatin resistance in retinoblastoma.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Negative Regulator Molecules
MicroRNAs
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

